Executive Summary San Francisco Science (SFS) is a medical technology incubator. Based in San Francisco, SFS is represented in San Jose, Seattle, Rome, Munich, Sydney, Auckland and Tel Aviv. The SFS strategy is to seek out and identify promising "break-through" medical technologies: technologies that offer unique (or radically different) solutions to existing medical problems. When we identify such technology, we acquire it, patent it, develop it, test it and bring it to market. Our primary focus, therefore, is in serving a project rather than a fund and, for that reason, before any outside (third party) funds are raised or committed, SFS finds the technology, identifies the market for that technology, protects that technology (through patents), assembles the right team for that technology and then, and only then, raises funds for that technology. SFS adopts a tailor-made approach for each of its portfolio technologies. Our motto is: "Not every technology, a company; Not every company, an IPO". In light of this philosophy, exit strategies and financing alternatives are always in the forefront of our considerations. Our team has extensive experience in product design and engineering, regulatory compliance, licensing, mergers and acquisitions and private and public financings. The Harvard Business School (HBS) has recognized SFS and includes the evolution and success of SFS among its textbook case studies. Jerry Sanders, SFS' founder, is profiled in HBS' "Entrepreneurship" class and its "Power and Influence" class. The "Jerry Sanders" case is also taught at Stanford's Business School and at Kellogg, Northwestern University's Business School. SFS welcomes inventors and investors into each of its portfolio companies on an ad hoc basis. For more information, please contact San Francisco Science at 415-561-2555 or innovation@sfsmed.com

Back to Home page